Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Tips and Info on AFM From an Experienced IP

    Tips and Info on AFM From an Experienced IP

    Disinfectants, visitor screening, and restriction

    December 1, 2018
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Special Report: Medical-legal consulting pearls from an experienced expert witness

    Women Who Experienced Miscarriage or Stillbirth Early in Life Have an Increased Risk of Stroke in Later Life

    The Joint Commission Update for Infection Control: Tips to conduct your annual IP risk assessment

    Related Products

    Special Report: Medical-legal consulting pearls from an experienced expert witness | Single Article

    Turnover's not a given; try these tips from an expert | Single Article

    Sue Dolan, RN, an infection preventionist at Colorado Children’s Hospital in Denver, has extensive experience dealing with acute flaccid myelitis (AFM) and the viruses that can trigger the paralytic condition.

    Dolan provided the following comments and tips for IPs to Hospital Infection Control & Prevention.

    Droplet Precautions for EV-D68, EV-A71

    Dolan: Many enteroviruses (EV) are primarily spread via the fecal-oral route, and contact precautions are sufficient. However, EV-D68 and EV-A71 act more like respiratory viruses. They are likely to spread person-to-person like other respiratory viruses through droplets via coughing and sneezing or by manual transfer of fomites from contaminated surfaces.

    The virus enters the nasopharynx and attaches to epithelial cells on mucosal surfaces and then initially spreads locally. In some patients, it becomes more invasive and can travel to other parts of the body like the central nervous system — causing neurological symptoms. It is unclear why this additional or severe invasive step occurs in some patients and not others.

    AFM Rehab

    Dolan: Specific [infection control] exceptions were developed for long-term patients needing therapy/rehabilitation outside their room to work toward improving their neurological deficits. Procedures were developed to allow for physical/occupational/speech therapy sessions at identified times and locations outside of the patient room. Practices were used by staff to protect themselves and other patients by proper use of PPE, patient transfer methods, and environmental disinfection.

    Disinfectants

    Dolan: EPA-approved hospital disinfectants with label indications against nonenveloped viruses [such as EV-D68] have broad efficacy and therefore also work against enveloped viruses.

    However, the label may not specifically designate activity against enveloped or nonenveloped viruses, so look for a claim of efficacy against at least one common nonenveloped virus. If present, then you are assured it will work for EV. These include norovirus, rotavirus, adenovirus, poliovirus, and rhinovirus.

    Visitor Screening

    Dolan: We consider this an important step year-round to prevent visitors from bringing in contagious illnesses and to protect our vulnerable patients, as well as staff and other visitors.
    (Continued on page 136)
    (Continued from page 135)

    At our hospitals, we routinely screen all visitors once a day for contagious illness symptoms or recent history prior to them entering the inpatient units. We ask about fever, rash, sore throat, cold, cough, runny nose, vomiting, diarrhea. We also ask about eye infection and active infection or recent exposure to chickenpox, measles, mumps, and tuberculosis. If they pass as not having any symptoms or exposures, they receive a sticker to wear showing they have been screened.

    Visitor Restrictions

    Dolan: During peak respiratory season, we have historically limited the number of visitors who can visit patients. This is an effort to decrease the burden of transmission risk during a time of multiple respiratory illnesses in the community.

    In 2014, we started these restrictions earlier than usual when we began seeing the unusual outbreak of EV-68 and the severity of the illness in some patients. Because the outbreak was new and the neurological findings on these patients very concerning, we limited visitation a few months earlier than the usual Dec. 1 start date.

    Also during this time in 2014, we limited and/or modified many of our community activities at the hospital in an effort to minimize transmission risk. Based on the knowledge gained in 2014, we did not need to implement additional visitor restrictions or limit community activities during the [current] outbreak and did not have any internal transmission at our facilities.

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Hospital Infection Control & Prevention

    View PDF
    Hospital Infection Control & Prevention (Vol. 45, No. 12) - December 2018
    December 1, 2018

    Table Of Contents

    What Is Causing Acute Flaccid Paralysis Syndrome in Children?

    Tips and Info on AFM From an Experienced IP

    AFM Peaking Every Other Year

    Hospital-acquired Pneumonia, C. diff Leading HAIs

    Get Patients ‘Up’ to Reduce Pneumonia, Other HAIs

    CDC Drafts Infection Control Guidelines for HCWs

    Presenteeism: Working Sick Appears to Be Endemic

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Peer Reviewer Patrick Joseph, MD, reports that he is a consultant for Genomic Health Reference Laboratory, Siemens Clinical Laboratory, and CareDx Clinical Laboratory. Senior Writer Gary Evans, Editor Jesse Saffron, Editor Jill Drachenberg, Nurse Planner Patti Grant, RN, BSN, MS, CIC, and Editorial Group Manager Terrey L. Hatcher report no consultant, stockholder, speaker’s bureau, research, or other financial relationships with companies having ties to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • My Subscription
      • Subscribe Now
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421 x 2

    International +1-404-262-5476 x 2

    Accounts Receivable

    1-800-688-2421 x 3
    ReliasMedia_AR@reliasmedia.com

    Sales

    1-800-688-2421 x 1

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2022 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing